David M. Faleck - Concepedia

Author

David M. Faleck

Memorial Sloan Kettering Cancer Center ORCID

Also Known As

D Faleck, D M Faleck, D. M. Faleck, David Faleck, David M Faleck, David M. Faleck

152

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center Icahn School of Medicine at Mount Sinai Montefiore Medical Center Cleveland Clinic Lenox Hill Hospital

About

David M. Faleck is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, inflammation, and gastroenterology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	132
2	Health Sciences	2	2	89
3	Biochemistry	1	1	50
4	Cell Biology	1	1	50
5	Diabetes	1	1	50

David M. Faleck

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Immune Checkpoint Inhibitor Therapy in Patients With Preexisting Inflammatory Bowel Disease Hamzah Abu‐Sbeih, David M. Faleck, Biagio Ricciuti, Journal of Clinical Oncology	2019	188
Open: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium Neeraj Narula, Farhad Peerani, Joseph Meserve, The American Journal of Gastroenterology	2018	171
Efficacy and safety of vedolizumab and infliximab treatment for immune-mediated diarrhea and colitis in patients with cancer: a two-center observational study Fangwen Zou, David M. Faleck, Anusha Shirwaikar Thomas, Journal for ImmunoTherapy of Cancer	2021	111
Beyond Steroids: Immunosuppressants in Steroid-Refractory or Resistant Immune-Related Adverse Events Jia Luo, Jason Beattie, Paige Fuentes, Journal of Thoracic Oncology	2021	103
Comparative safety and effectiveness of tumor necrosis factor α antagonists and vedolizumab in elderly IBD patients: a multicentre study Tomer Adar, David M. Faleck, Saranya Sasidharan, Alimentary Pharmacology & Therapeutics	2019	95
Phase II Single-arm Study of Durvalumab and Tremelimumab with Concurrent Radiotherapy in Patients with Mismatch Repair–proficient Metastatic Colorectal Cancer Neil H. Segal, Andrea Cercek, Geoffrey Y. Ku, Clinical Cancer Research	2021	84
Retrospective Analysis of Safety of Vedolizumab in Patients With Inflammatory Bowel Diseases Joseph Meserve, Satimai Aniwan, Jenna L. Koliani‐Pace, Clinical Gastroenterology and Hepatology	2018	81
Development and Validation of Clinical Scoring Tool to Predict Outcomes of Treatment With Vedolizumab in Patients With Ulcerative Colitis Parambir S. Dulai, Siddharth Singh, Niels Vande Casteele, Clinical Gastroenterology and Hepatology	2020	76
Predictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease Eugenia Shmidt, Gursimran Kochhar, Justin Hartke, Inflammatory Bowel Diseases	2018	74
Preoperative and Intraoperative Measurements of Urethral Length as Predictors of Continence After Robot-Assisted Radical Prostatectomy A. Ari Hakimi, David M. Faleck, Ilir Agalliu, Journal of Endourology	2011	72

Page 1